Infectious Diseases Society of America

Infectious Diseases Society of America
Name	Infectious Diseases Society of America
Formation	1963
Headquarters	United States
Membership	physicians, scientists, clinicians
Leader title	President

Infectious Diseases Society of America is a professional association of physicians, scientists, and healthcare professionals focused on the diagnosis, treatment, prevention, and research of infectious diseases. The Society engages with clinical practice, scientific research, public health response, and policymaking through multidisciplinary collaboration with hospitals, universities, and federal agencies. Its work intersects with outbreak response, antimicrobial stewardship, and guideline development affecting patient care in settings from academic medical centers to community clinics.

History

Founded in 1963 during a period of rapid expansion in medical sub-specialization, the Society emerged amid contemporaneous developments at institutions such as Johns Hopkins Hospital, Massachusetts General Hospital, Mayo Clinic, and University of California, San Francisco. Early leaders included faculty with affiliations to Harvard Medical School, Stanford University School of Medicine, and University of Pennsylvania School of Medicine, who responded to challenges exemplified by events like the 1957 influenza pandemic and research milestones at the National Institutes of Health. Throughout the late 20th century the Society engaged with responses to the HIV/AIDS epidemic, collaborated with agencies including the Centers for Disease Control and Prevention, Food and Drug Administration, and World Health Organization, and addressed antimicrobial resistance highlighted in initiatives such as reports from the Institute of Medicine.

Mission and Activities

The Society’s mission emphasizes excellence in patient care, research, and public health through networking with entities like Association of American Medical Colleges, American Medical Association, and specialty societies including the American College of Physicians and American Academy of Pediatrics. Its activities span clinical guideline development with partners such as the Joint Commission, participation in outbreak advisory panels for events like the 2009 H1N1 pandemic and the 2014–2016 West Africa Ebola epidemic, and research advocacy aligned with funding bodies such as the National Institute of Allergy and Infectious Diseases and National Institutes of Health. The Society also collaborates with global health organizations including Doctors Without Borders and academic consortia at Columbia University Irving Medical Center and Yale School of Medicine.

Guidelines and Publications

The Society produces clinical practice guidelines, position papers, and consensus statements utilized by clinicians at institutions like Cleveland Clinic and Mount Sinai Health System. Publications include peer-reviewed journals and recommendations that interface with literature from journals such as The New England Journal of Medicine, Journal of the American Medical Association, and Lancet Infectious Diseases. Guidelines address topics including antimicrobial stewardship, management of bloodstream infections, and prophylaxis for transplantation, and are developed through panels with experts from American Society of Transplantation, Society of Critical Care Medicine, and specialty task forces formed after public health events like the 2003 SARS outbreak.

Education and Training

The Society coordinates continuing medical education programs, fellowship standards, and training resources used by programs at centers including University of California, Los Angeles, University of Michigan Medical School, and Washington University School of Medicine. Educational offerings include annual meetings that attract speakers from institutions such as National Institutes of Health, Centers for Disease Control and Prevention, and international partners like London School of Hygiene & Tropical Medicine. The Society also supports career development through mentorship initiatives, research grants, and collaboration with certification boards such as the American Board of Internal Medicine.

Advocacy and Policy

The Society advocates on policy matters including antimicrobial resistance, vaccination, and outbreak preparedness, engaging with legislators on Capitol Hill and agencies like the Department of Health and Human Services and Agency for Healthcare Research and Quality. Policy work has intersected with legislative efforts related to drug development incentives discussed in hearings involving the Senate Committee on Health, Education, Labor, and Pensions and funding priorities set by the House Committee on Appropriations. The Society issues public statements during crises such as the COVID-19 pandemic (2020–present) and collaborates with coalitions including the Global Health Security Agenda.

Membership and Governance

Membership comprises clinicians, researchers, and trainees associated with medical centers such as Beth Israel Deaconess Medical Center, University of Chicago Medicine, and Emory University Hospital. Governance structures include an elected board and committees interacting with professional organizations like the Association of Professionals in Infection Control and Epidemiology and regulatory stakeholders such as the Centers for Medicare & Medicaid Services. The Society’s leadership has historically included faculty who hold appointments at institutions like Duke University School of Medicine and University of California, San Diego School of Medicine and who participate in international advisory roles with agencies such as the Pan American Health Organization.

Category:Medical associations Category:Infectious disease organizations